David Allan

David Allan

Ottawa University

H-index: 42

North America-United States

About David Allan

David Allan, With an exceptional h-index of 42 and a recent h-index of 30 (since 2020), a distinguished researcher at Ottawa University, specializes in the field of endothelial progenitor, mesenchymal stromal cells, experimental cell therapy, regenerative therapy, bone marrow transplantation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of donor age on allogeneic hematopoietic cell transplantation outcomes in older adults with acute myeloid leukemia

Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review

Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?

Clinical outcomes of umbilical cord blood transplantation using ex vivo expansion: a systematic review and meta-analysis of controlled studies

Humoral and cellular response of transplant recipients to a third dose of mRNA SARS-CoV-2 vaccine: a systematic review and meta-analysis

A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services’ Cord Blood Bank: First Analysis

Comparison of allogeneic hematopoietic cell transplantation outcomes from younger matched unrelated donor versus older sibling donor for acute myeloid leukemia

Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID‐19 pandemic: A Canadian Blood Services Stem Cell Registry analysis

David Allan Information

University

Position

Ottawa Hospital Research Institute Canadian Blood Services

Citations(all)

5433

Citations(since 2020)

3136

Cited By

3553

hIndex(all)

42

hIndex(since 2020)

30

i10Index(all)

97

i10Index(since 2020)

74

Email

University Profile Page

Google Scholar

David Allan Skills & Research Interests

endothelial progenitor

mesenchymal stromal cells

experimental cell therapy

regenerative therapy

bone marrow transplantation

Top articles of David Allan

Impact of donor age on allogeneic hematopoietic cell transplantation outcomes in older adults with acute myeloid leukemia

Transplantation and Cellular Therapy

2023/9/1

Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review

2022/7/3

Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?

2024/3/1

Clinical outcomes of umbilical cord blood transplantation using ex vivo expansion: a systematic review and meta-analysis of controlled studies

2023/2/1

Humoral and cellular response of transplant recipients to a third dose of mRNA SARS-CoV-2 vaccine: a systematic review and meta-analysis

2023/1/1

A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services’ Cord Blood Bank: First Analysis

Current Oncology

2022/12/6

Comparison of allogeneic hematopoietic cell transplantation outcomes from younger matched unrelated donor versus older sibling donor for acute myeloid leukemia

Blood

2022/11/15

Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID‐19 pandemic: A Canadian Blood Services Stem Cell Registry analysis

Vox Sanguinis

2022/9

Systematic scoping review of studies reporting unexpected donor-derived abnormalities from recipients of allogeneic hematopoietic cell transplantation: a proposed framework for …

2022/7/1

Updated living systematic review and meta-analysis of controlled trials of mesenchymal stromal cells to treat COVID-19: a Framework for Accelerated Synthesis of Trial Evidence …

2022/7/1

Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19

2022/6/1

The hunt is on! In pursuit of the ideal stem cell population for cartilage regeneration

2022/5/27

Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies

2022/4/1

Development and evaluation of checklists to support the recruitment of committed hematopoietic stem cell donors

Transfusion

2022/4

David Allan
David Allan

H-Index: 28

MSC-derived extracellular vesicles to heal diabetic wounds: a systematic review and meta-analysis of preclinical animal studies

2022/3

MSC-derived extracellular vesicles in preclinical animal models of bone injury: a systematic review and meta-analysis

2022/3/1

Autologous hematopoietic stem cell transplantation for liver transplant recipients with recurrent primary sclerosing cholangitis: a pilot study

2022/12

A portrait of SARS-CoV-2 infection in patients undergoing hematopoietic cell transplantation: a systematic review of the literature

2022/1/13

Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis

2022/12/6

Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: perspectives of the most‐needed donors

Transfusion

2021/1

See List of Professors in David Allan University(Ottawa University)

Co-Authors

academic-engine